'Dynamic' Phlexglobal Impresses Judges To Secure Investors In People Status
Phlexglobal Ltd, the specialist CRO for clinical trial administration and study site support, has secured the coveted Investors in People (IiP) status and has been recognised by assessors as a model of excellence.
The company, which specialises in resourcing, training and clinical research services counts 15 of the top 20 pharmaceutical companies across the globe as its clients and is based in Amersham, Buckinghamshire.
Its imaginative and participative approach to business development and providing a first class service to customers were all singled out for praise by the IiP assessors after an intensive two-day audit, as was the way the company has coped with rapid growth and an expanding market share, which has made it the market leader in clinical trial administrative support.
Indeed, assessors went further, commenting: "Phlexglobal is a dynamic company - with an imaginative and participative approach to business development and providing first class service to customers. The management team are organised, effective and have plans for continuing improvement. They value and develop their staff and have established a sound foundation of good management practice.
"The company has exciting and challenging plans for continuing growth, and demonstrates how using the standard of Investors in People can provide a framework for success."
Investors in People is designed to recognise companies which genuinely train staff and recognise the importance of on-going personnel development. The process entailed a pre-audit by IiP assessors which was then followed by a much more detailed on-site audit.
Phlexglobal's head of training and personal development, Dr Gareth Hayes, believes it is the focus on quality, flexibility and adaptability which has allowed it to go from strength to strength in recent years, explaining:
"Delivering excellent service is not just about numbers, it requires our staff to focus on building relationship with clients, learning and understanding their business, their ethos and looking for the best fit. Training and education is key to our success and personal development programmes form a major part of our core business strategy.
"This success has been a team effort and it is fantastic for everyone that all of the hard work in building this thriving working environment and team spirit has been recognised and praised by such a well-respected body as Investors in People. However, we will not be resting on our laurels. This is a strong foundation to take the business even further forward as we enter a very exciting time of growth for the business."
Most read news
Organizations
Other news from the department business & finance

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
Viral life cycle of malignant catarrhal fever explained
Rare genetic disease successfully reversed using stem cell transplantation - Scripps Research scientists correct gene defect in mice that causes lethal symptoms in children
